KDM6A and urinary bladder carcinoma: In addition, mucoadhesive mRNA nanoparticles used for the intravesical delivery of KDM6A-mRNA in mice bearing orthotopic Kdm6a-null bladder cancer reduced bladder size and weight, and significantly decreased lymph node volume and Ki-67 expression [112].